BDBM235825 US9364459, M

SMILES COc1cc(cc(OC)c1OC)C1=C(C(=O)NC1=O)c1cn(CCN2CCOCC2)c2ccccc12

InChI Key InChIKey=BWYFZMARRPMNBE-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 235825   

TargetGlycogen synthase kinase-3 beta(Human)
Johannes Gutenberg-UniversitäT Mainz

US Patent
LigandPNGBDBM235825(US9364459, M)
Affinity DataIC50: 657nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz

US Patent
LigandPNGBDBM235825(US9364459, M)
Affinity DataIC50: 9.20E+3nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg-UniversitäT Mainz

US Patent
LigandPNGBDBM235825(US9364459, M)
Affinity DataIC50: 1.00E+4nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent